Needham analyst Michael Matson has maintained their bullish stance on LIVN stock, giving a Buy rating on October 31. Michael Matson has given ...

"I'm using [Ozempic] off-label for a whole host of conditions — and have been for years," Dr. Caroline Messer, an ...

The devices work well for people with mild or moderate sleep apnea, but less well for older people, people with obesity and ...

I’m sorry to hear your CPAP mask is keeping you awake at night, but I’m happy to hear that you’re addressing your obstructive ...

Physiological systems in the human body interact throughout life, exhibiting specific patterns during sleep. These networked patterns are present from birth, and are sculpted by varies physiological ...

LivaNova met the primary endpoints for its OSPREY trial, Treating Obstructive Sleep Apnea Using Targeted Hypoglossal Nerve Stimulation.

Think of the heart as a pump that works tirelessly every day. But sometimes, this pump starts to weaken, which is what ...

C-reactive protein (CRP) levels may be a biomarker for cardiometabolic risk and insulin resistance among adults with mild to moderate obstructive sleep apnea (OSA) aged less than 60 years, according ...

Army veteran Bryan Vadney used to love life, was being active, spent time with family and friends, and took part in his ...

LivaNova (Nasdaq:LIVN) today announced that its OSPREY trial of nerve stimulation for treating sleep apnea met its primary ...